Sartorius Stedim Biotech SA Reports Share and Voting Rights Data

Sartorius Stedim Biotech SA has released updated information regarding its capital structure. As of May 31, 2026, the company disclosed that the total number of shares comprising its issued capital stands at 97,330,405. Correspondingly, the total number of theoretical voting rights, including treasury shares, amounts to 164,770,837. The net voting rights, however, total 164,734,232.

This declaration was made in accordance with Article L 233-8-II of the Code of Commerce and Article 223-6 of the AMF's general regulations. Sartorius Stedim Biotech SA is established in Aubagne, France, and publicly shares this regulatory information as part of its commitment to transparency and regulatory compliance in the financial markets.